Abstract:Silver nanoparticles (AgNPs) have garnered significant interest due to their distinctive properties and potential applications. Traditional fabrication methods for nanoparticles often involve high-energy physical conditions and the use of toxic solvents. Various green synthesis approaches have been developed to circumvent these issues and produce environmentally benign nanoparticles. Our study focuses on the green synthesis of AgNPs using L-ascorbic acid and explores the modification of their properties to enhance antibacterial and anticancer effects. This is achieved by coating the nanoparticles with Zinc oxide (ZnO) and Silica oxide (SiO 2 ), which alters their optical properties in the visible spectrum. The synthesized formulations—AgNPs, zinc oxide-silver nanoparticles (Ag@ZnO), and silica oxide-silver nanoparticles (Ag@SiO 2 ) core/shell nanoparticles—were characterized using a suite of physicochemical techniques, including Transmission Electron Microscopy (TEM), Dynamic Light Scattering (DLS), Zeta potential measurement, UV–Vis spectroscopy, Refractive Index Measurements, and Optical Anisotropy Assessment. TEM imaging revealed particle sizes of 11 nm for AgNPs, 8 nm for Ag@ZnO, and 400 nm for Ag@SiO 2 . The Zeta potential values for Ag@ZnO and Ag@SiO 2 were measured at −17.0 ± 5 mV and −65.0 ± 8 mV, respectively. UV–Vis absorption spectra were recorded for all formulations in the 320 nm to 600 nm wavelength range. The refractive index of AgNPs at 404.7 nm was 1.34572, with slight shifts observed for Ag@ZnO and Ag@SiO 2 to 1.34326 and 1.37378, respectively. The cytotoxicity of the nanocomposites against breast cancer cell lines (MCF-7) was assessed using the MTT assay. The results indicated that AgNPs and Ag@ZnO exhibited potent therapeutic effects, with IC50 values of 494.00 μg/mL and 430.00 μg/mL, respectively, compared to 4247.20 μg/mL for Ag@SiO2. Additionally, the antibacterial efficacy of AgNPs was significantly enhanced under visible light irradiation. Ag@ZnO demonstrated substantial antibacterial activity both with and without light exposure, while the Ag@SiO2 nanocomposites significantly reduced the inherent antibacterial activity of silver. Conversely, the Ag@ZnO nanocomposites displayed pronounced antibacterial and anticancer activities. The findings suggest that silver-based nanocomposites, particularly Ag@ZnO, could be practical tools in water treatment and the pharmaceutical industry due to their enhanced therapeutic properties.

A crossover study of antimicrobial capacity and biotoxicity of silver nanoparticles

The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity

Mycogenic silver nanoparticles (from Penicillium citrinum IB-CLP11) – their antimicrobial activity and potential toxicity effects on freshwater organisms.

In vitro evaluation of silver nanoparticles on human tumoral and normal cells

Functional silver-based nanomaterials affecting zebrafish development: the adverse outcomes in relation to the nanoparticle physical and chemical structure

Effects of mycogenic silver nanoparticles on organisms of different trophic levels

Long-term effects of silver nanoparticles in caco-2 cells

Antibacterial efficacy of novel bismuth-silver nanoparticles synthesis on Staphylococcus aureus and Escherichia coli infection models

Applications and toxicity of silver nanoparticles: a recent review

Bactericidal and Cytotoxic Properties of Silver Nanoparticles

Silver Nanoparticles: in Vivo Toxicity in Zebrafish Embryos and a Comparison to Silver Nitrate

In Vitro Effects of Silver Nanoparticles on Pathogenic Bacteria and on Metabolic Activity and Viability of Human Mesenchymal Stem Cells

Cytokinesis-Block Micronucleus Assay Using Human Lymphocytes as a Sensitive Tool for Cytotoxicity/Genotoxicity Evaluation of AgNPs

Using single-species and algal communities to determine long-term adverse effects of silver nanoparticles on freshwater phytoplankton

Biosynthesis of Silver Nanoparticles From Marinobacter litoralis CARE V18 Strain and Evaluation of Its Antibacterial, Antioxidant and Cytotoxicity Properties Using Zebrafish Model

Differential antimicrobial activity of silver nanoparticles to bacteria Bacillus subtilis and Escherichia coli, and toxicity to crop plant Zea mays and beneficial B. subtilis-inoculated Z. mays

Evaluation of the toxicities of silver and silver sulfide nanoparticles against Gram-positive and Gram-negative bacteria

Evaluation of Biological Effects and Toxicity of Cetyltrimethylammonium Bromide Stabilized Silver Nanoparticles and Cetyltrimethylammonium Bromide Alone Following Intravenous Injection in Mice

Nanosilver capping drives behavior, dissolution and (eco)toxicity to microorganisms and mammalian cells

Assessment of the Effect of Surface Modification of Metal Oxides on Silver Nanoparticles: Optical Properties and Potential Toxicity

Impact of nanosilver surface electronic distributions on serum protein interactions and hemocompatibility